Immunosuppression involves an inability to control virus infections and increased incidence of virus-associated cancers. Some cancers without known viral etiology are also increased, but data on exactly which cancer forms are increased has been inconsistent. To provide a reliable and generalizable estimate, with high statistical power and long follow-up time, we assessed cancer risks using comprehensive, population-based registries in two different countries and from two different immunosuppressed patient groups (solid organ transplant recipients (OTRs) and long-term dialysis patients (LDPs)). National registries in Denmark and Sweden identified 20,804 OTRs and 31,140 LDPs that were followed up using national cancer registries. Standardized incidence ratios (SIR) compared to the general population were estimated. We found highly similar results, both for the two different countries and for the two different immunosuppressed cohorts, namely an increased incidence for the following specific cancer forms: Non-melanoma skin cancer (NMSC), non-Hodgkin's lymphoma and cancers of the lip, kidney, larynx and thyroid. The SIR for overall cancer among OTRs was 3.5 [n 5 2,142, 95% CI, 3.4-3.7] in Sweden, 2.9 [n 5 1,110, 95% CI, 2.8-3.1] in Denmark and 1.6 [n 5 1,713, 95% CI, 1.5-1.6] among LDP. The SIR for NMSC among OTRs was 44.7 [n 5 994, 95% CI, 42-47.5] in Sweden and 41.5 [n 5 445, 95% CI, 37.8-45.5] in Denmark. The increased SIR for NMSC among LDPs was 5.3 [n 5 304, 95% CI, 4.7-5.9]). In summary, an increased SIR for a specific, similar set of cancer forms is consistently found among the immunosuppressed. Conceivable explanations include surveillance bias and immunosuppression-related susceptibility to viral infections.
Introduction
Several human cancers have a greatly increased incidence in individuals whose cellular immune system is impaired. Severe immunosuppression in high-resource countries is mostly in conjunction with solid organ transplantation. 1 Most of these cancers are known to be caused by viruses (for example Kaposi sarcoma (human herpes virus 8), non-Hodgkin lymphoma (human herpesvirus 8 and Epstein-Barr virus), Hodgkin lymphoma (Epstein-Barr virus), liver cancer (hepatitis C and B viruses) and cancers of the cervix, vulva, vagina, penis, anus and oropharynx (human papillomavirus (HPV)). 1, 2 The two major forms of non-melanoma skin cancers (NMSC), squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), are two of the most prevalent cancers among Caucasian populations worldwide. Solid organ transplant recipients (OTRs) have an approximately a 65-to 100-fold increase in SCC; 3-6 a 2-to 16-fold increase in BCC 7, 8 and 10-fold increase in Merkel cell carcinoma 9 compared to the general population, suggesting that the development of these cancers is normally controlled by immune system functions that are being suppressed in OTR. A suggested explanation is that the immune system may target a viral antigen expressed in precancerous cells. [3] [4] [5] [6] Patients on long-term dialysis also are at risk of immunosuppression due to multiple transfusions. If the increase in a specific set of cancer forms as is seen in OTRs would indeed by due to the immunosuppression, a similar increase in the same set of specific cancers may be expected. However, only a small number of studies have investigated the risk of cancer among these patients and conflicting results were produced.
Registers using surgical procedure codes. National Patient Registers are registering all hospital discharges and surgical procedures of individuals since 1964 in Sweden 14 and in Denmark since 1977. 15 In Denmark, we also used the Patient Registry to identify the patients who were on long-term dialysis treatment.
These cohorts were linked to the Danish and Swedish population-based cancer registries, using the unique personal identification number, to identify which patients developed subsequent cancer. Population-based and countrywide Nordic cancer registries were established almost 50 years ago and are notified of virtually all histologically confirmed new cases of cancer. 16 Nordic cancer registries are considered to have a consistently high degree of comparability and completeness over time. 16 The follow-up started on the date of the transplantation/ dialysis treatment and ended on the date of first primary cancer diagnosis, death, emigration or the closing date of the study (December 31, 2011 in Sweden and December 31, 2013 in Denmark), whichever occurred first. Cancers occurring within six month after transplantation/dialysis were excluded from the analysis. Benign tumors were also excluded. If a person from the dialysis treatment cohort later received a transplantation he was censored from the dialysis cohort and moved to the transplantation cohort.
Statistical analyses
The observed subsequent primary cancers, occurring at least six months after the start of follow up, were compared to those expected by incidence rates among the national populations. To estimate the expected number of cancers, the Nordic Cancer Registries (NORDCAN) incidence rates* specific for country, age, gender, 5-year calendar period and anatomical site were multiplied by the respective numbers of accumulated person-years at risk. The ratio of observed-to-expected number of cases was expressed as the standardized incidence ratio (SIR). Risks were also estimated stratified by type of procedure (organ transplantation or dialysis treatment). Ninety-five percent confidence intervals of SIR were computed assuming a Poisson distribution for observed cases. Findings were considered significant for two-sided p < 0.05. (1,009 in Sweden and 581 in Denmark) patients (7.6%) were excluded from further analyses due to cancer diagnosis before receiving organ transplantation. The final cohort of solid OTRs consisted of 12,420 individuals in Sweden and 6,794 individuals in Denmark. From the cohort of patients on long-term dialysis a total of 6,442 (21%) patients were excluded from further analysis as they had already been diagnosed with cancer before receiving their 1st dialysis. The final cohort consisted of 24,698 individuals.
OTRs in Sweden comprised 7,729 men and 4,691 women (Table 1) , with mean ages of 46 years and 45 years, respectively. They were observed for a mean of 8.6 years and 9 years, respectively, from the transplantation (if followed until any type of cancer diagnosis). The longest individual followup time was 46.8 years (when followed until any type of cancer diagnosis), from receiving organ transplantation, accruing 2,142 cancers and 107,988.5 person-years (when followed until diagnosis of any type of cancer). Some patients developed several different types of cancers, accruing a total of 2,550 incident cancers (Table 1) .
Patients on long-term dialysis alone comprised 15,346 men and 9,352 women, with mean ages of 61 years at the start of the procedure. They were observed for a mean of 3.2 years, from the start of dialysis, accruing 1,713 cancers and 79,881 person-years (when followed until diagnosis of any type of cancer) and a total of 1,873 incident cancers ( Table  1 ). The OTRs were 3,840 men and 2,954 women. The mean age was 44 years at the time of transplantation. Mean observation times were 9 years (from receiving organ transplantation), accruing 1,110 cancers and 60,803 person-years (when followed until diagnosis of any type of cancer) and a total of 1,286 incident cancers ( Table 1 ). The longest individual follow-up time was 36.7 years.
Kidney recipients constituted the majority of all patients (9,427 in Sweden and 4,428 in Denmark), followed by liver (1,754 in Sweden and 609 in Denmark), heart (894 in Sweden and 506 in Denmark), lung (584 in Sweden and 471 in Denmark), heart and lung (13 in Sweden and 8 in Denmark), pancreas (292 in Sweden), islet cells (74 in Sweden), Thyroid What's new? While immunosuppression greatly increases the risk of virus-associated cancers, studies on solid organ transplant recipients (OTRs) suggest that suppressed immune function also increases the risk for cancers without known viral causes. In this analysis of data from cancer registries in Sweden and Denmark, the incidence of several cancers was found to be consistently increased both in OTRs and in patients on long-term dialysis. The cancers included nonmelanoma skin cancer, non-Hodgkin's lymphoma and malignancies of the lip, kidney, larynx and thyroid. The findings warrant further study of immune involvement and a possible infectious etiology for the cancer types identified. Tables 2, 3 , and 4 BBC is not included among NMSCs. Table describes entire cohort (cancer free patients, as well as all patients with incidence cancers). Some of the patients had several incidence cancers and contributed to several age groups.
*NORDCAN does not include BCC, thus in
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Hortlund et al. Cancer Epidemiology Cancer Epidemiology (852 in Denmark) and small Intestine (31 in Sweden and 7 in Denmark). In analyses of subgroups, we combined heart or lung transplant recipients with heart and lung transplant recipients during stratified analysis of cancer risk based on types of organs transplanted.
Patients that received solid organ transplantation had a greater risk for cancer than expected in a gender-, age-and calendar period-matched general population. The overall SIR for any subsequent cancer at any site, occurring at least after six months, was 3.5 (n 5 2,142, 95% CI, 3.4-3.7) and 2.9 (n 5 1,110, 95% CI, 2.5-3.1) in Sweden and in Denmark, respectively (Tables 2 and 3 ). The most frequent primary cancer was non-melanoma skin cancer (Sweden: n 5 994; SIR, 44.7; 95% CI, 42-47.5. Denmark: n 5 445; SIR 41.5; 95% CI, 37.8-45.5). The risks of lip (Sweden: n 5 88; SIR, 41.5; 95% CI, 33.7-51.1. Denmark: n 5 11; SIR, 12.7; 95% CI, 7.1-23), non-Hodgkin lymphoma (Sweden: n 5 169; SIR, 7.9; 95% CI, 6.8-9.2. Denmark: n 5 58; SIR, 5.1; 95% CI, 4.0-6.6), Kidney (Sweden: n 5 100; SIR, 5.8; 95% CI, 4.8-7. Denmark: n 5 48; SIR, 5.9; 95% CI, 4.4-7.8) and Thyroid (Sweden: n 5 24; SIR, 4.9; 95% CI, 3.3-7.3. Denmark: n 5 10; SIR 4.2; 95% CI, 2.2-7.7) were also significantly increased (Tables 2 and 3 ).
In the long-term dialysis cohort, the overall SIR for any subsequent cancer at any site, occurring at least after six months, was 1.6 (n 5 1,713, 95% CI, 1.5-1.6). The most frequent primary cancer was NMSCs (n 5 304; SIR, 5.3; 95% CI, 4.7-5.9). The risks of lip cancer (n 5 9; SIR, 3.9; 95% CI, 2.0-7.5), non-Hodgkin lymphoma (n 5 50; SIR, 1.6; 95% CI, 1.2-2.2), Kidney cancer (n 5 62; SIR, 2.8; 95% CI, 2.2-3.7) and Thyroid cancer (n 5 10; SIR, 2.9; 95% CI, 1.6-5.4) were also significantly increased (Table 3) .
NMSC were highly elevated among OTRs receiving different types of transplants, especially in heart and lung transplant cohort patients (Table 4 ). The patients receiving dialysis treatment also had an increased NMSC risk, but it was (compared to the general population) 7-10 times lower than among the heart, kidney and liver transplant recipients, respectively (Table 4 ).
Discussion
We report that a large cohort of the patients that had received solid organ transplantation in two different countries were at increased risk for a specific subset of cancers, in particular NMSC, lip, kidney, thyroid, larynx, bladder, lung and colon, multiple myeloma and melanoma. Similar risk elevations for the different forms of cancer were seen in the 2 
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countries studied (Sweden and Denmark). Although the cancer risks were not as highly elevated for dialysis patients, it is striking that the specific cancer forms that were increased among dialysis patients were largely the same cancer forms as are also increased among OTRs. Although we excluded cases occurring <6 months after organ transplantation or start of long-term dialysis, surveillance bias should always be considered as an explanation for excess cancer risk.
The comparison with dialysis patients is of particular interest to disentangle effects of immunosuppression and possible side effects of the immunosuppressive therapy itself. Patients on long-term dialysis do not receive immunosuppressive therapy, but are at risk of immunosuppression due to multiple transfusions. Higher risks of cancers, and especially NMSCs, were observed in heart and lung transplant patients, compared to kidney and liver transplant recipients. This effect was also observed in previous investigations 1, [17] [18] [19] [20] and could be attributed to a higher degree of immunosuppressive therapy. Some studies suggested that the elevated risk after organ transplantation is attributed not only to the degree of immunosuppression but also to the tumorigenic effects of the immunosuppressive drugs as well. 21 However, a lower degree of immunosuppression is a likely explanation for the comparatively lower increases seen among dialysis patients, who do not receive immunosuppressive drugs. A previous investigation has also indicated that after the stopping or reducing of immunosuppressive therapy among kidney transplant recipients, the increased risk of virusassociated cancers reversed back to the lower levels observed in dialysis patients. 22 In addition possible oncogenic factors that OTR are exposed compared to long-term dialysis recipients are antigenic stimulation from the graft, donor transmitted oncogenic viruses and donor-derived cancers. 1 The major strength of our study is that (1) patients exclusively on dialysis and OTRs originated from the same population, (2) were identified from population-based inpatient registries and (3) cancer cases from cancer registries of two Nordic countries. Population-based and countrywide Nordic cancer registries were established almost 50 years ago and they are notified of virtually all histologically confirmed new cases of cancers from welldefined populations. 16 The fact that we identified cancer cases exactly the same way as the cancer incidence rates of the general population, makes ascertainment bias highly unlikely.
Immunosuppressed patients, such as OTRs and/or HIV positive individuals, have an increased prevalence of both single and multiple HPV infections, compared to the healthy population. 23 The fact that almost all cancers that are known to be caused by viruses are increased in immunosupressed individuals implies that immunosuppression induces an impaired ability to control tumorigenic viruses. 1, 2, 24 Some of the cancers that were increased among OTRs such as NMSCs, [25] [26] [27] [28] head and neck cancers, 29 thyroid [30] [31] [32] and colorectal cancers 33 have had a virus-association proposed, but with inconsistent results. [33] [34] [35] Cohorts of OTRs provide a unique study setup for investigating causal mechanisms for carcinogenesis by evaluating genetic and microbiome profiles by modern day next generation sequencing (NGS) technologies. Harald zur Hausen has pointed out that exploration of any further role of infections in cancer is likely to be particularly rewarding if focused on the cancer forms that are increased among the immunosuppressed, but that do not have any established microbiological etiology.
